FDA Investigator John F Cipollo
John F Cipollo has inspections in 3 countries as of 28 Jun 2023. John F Cipollo has collaborated with a combined 895 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
5
Last Inspection Date:
28 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Ireland,
Germany,
Italy
Co-Investigator(s):
Alicia M Mozzachio,
Anissa M Cheung,
Bijoy Panicker,
Burnell M Henry,
CDR Donald Ertel,
Cynthia Jim, CSO,
Cynthia Kelley,
Darla J Christopher,
Dino Feigelstock (DF), PhD,
Dmitriy V Volokhov, PhD,
Dr. Willie F Vann, PhD,
Ellen Huang,
Gene D Arcy,
Helen B Ricalde,
J David Doleski,
Jacqueline Mdiaz Albertini,
Joseph George,
Justin A Boyd,
Kelly R Lewis,
Kirsten L Vadheim, PhD,
Kirsten L Vodheim, PhD,
Laurie P Norwood,
LCDR Debra Emerson,
Leslie D Wagner,
Linda R Kuchenthal,
Linda Thai,
Lisa M Parsons,
Madushini Dharmasena, PhD,
Marion Michaelis,
Michele L Obert,
Mihaly S Ligmond,
Nancy T Waites,
Nicole K Trudel,
Omotunde O Osunsanmi,
Pankaj H Amin,
Patrick C Klotzbuecher,
Paula A Trost,
Prabhu P Raju,
Rebecca K Olin,
Richard W Thornton,
Robert D Tollefsen,
Robert W Jennings,
Robin Levis, PhD,
Rose M Ashley,
Scott E Norris,
Sean R Bryd,
Susan M Jackson,
Tim S Roecklein,
Tina S Roecklein
John F Cipollo's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2017 | FDA 483 | GlaxoSmithKline Vaccines Srl - Form 483, 2017-05-29 |
June, 2015 | FDA 483 | GlaxoSmithKline Vaccines Srl - Form 483, 2015-06-26 |
September, 2016 | FDA 483 | Pfizer Ireland Pharmaceuticals - Form 483, 2016-09-20 |
May, 2017 | FDA 483 | GSK Vaccines S.r.l. - Form 483, 2017-05-29 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more